Translate
Nextcure Inc
About
Nextcure Inc (NASDAQ:NXTC) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2026
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
Mar 31 2026
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
Mar 5 2026
NextCure Provides Business Update and Reports Full Year 2025 Financial Results
Jan 23 2026
NextCure Provides Business Update
Jan 23 2026
NextCure Provides Business Update
Financials
Revenue
$0
Market Cap
$38.17 M
EPS
-19.65